Do hepatic artery infusion pumps cause recurrent pleural effusions?

J Surg Case Rep. 2020 Aug 24;2020(8):rjaa137. doi: 10.1093/jscr/rjaa137. eCollection 2020 Aug.

Abstract

Hepatic artery infusion pump chemotherapy (HAIPC) for colorectal liver metastasis (CRLM) is a new technique in the treatment of CRLM, whose side effects are not well studied. Case Report: This paper aims to understand the side effect profile of HAIPC as it relates to recurrent pleural effusions. This is a case report of a 48-year-old male with CRLM being treated with HAIPC, who presents with recurrent pleural effusions found to be benign/transudative after right-side video-assisted thoracoscopic surgery. Discussion: This study suggests that HAIPC causes recurrent sympathetic pleural effusions as a side effect of the perihepatic inflammation of the localized chemotherapy treatment. Furthermore, we question if sympathetic pleural effusions are a prelude to hepatic toxicity from HAIPC. Lastly, this paper aims to guide the differential diagnosis of pleural effusions in the cancer patient being treated with HAIPC.

Keywords: cancer; colorectal; effusion; hepatic artery infusion pump; metastatic.

Publication types

  • Case Reports